TCAF2 and neoplasm: TCAF2 is highly expressed in tumor pericytes (TPCs) derived from patients with colorectal cancer liver metastasis (CRCLM), which induces the secretion of Wnt5a through inhibiting TRPM8 channel and activates the STAT3 phosphorylation in tumor cells, thus facilitating CRCLM.